Cargando…
Use of Serum MicroRNAs as Biomarker for Hepatobiliary Diseases in Dogs
BACKGROUND: Current biochemical indicators cannot discriminate between parenchymal, biliary, vascular, and neoplastic hepatobiliary diseases. MicroRNAs are promising new biomarkers for hepatobiliary disease in humans and dogs. OBJECTIVE: To measure serum concentrations of an established group of mic...
Autores principales: | Dirksen, K., Verzijl, T., Grinwis, G.C., Favier, R.P., Penning, L.C., Burgener, I.A., van der Laan, L.J., Fieten, H., Spee, B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5115189/ https://www.ncbi.nlm.nih.gov/pubmed/27859748 http://dx.doi.org/10.1111/jvim.14602 |
Ejemplares similares
-
Sensitivity and Specificity of Plasma ALT, ALP, and Bile Acids for Hepatitis in Labrador Retrievers
por: Dirksen, K., et al.
Publicado: (2017) -
Association of circulating microRNA‐122 and microRNA‐29a with stage of fibrosis and progression of chronic hepatitis in Labrador Retrievers
por: Sakai, Manabu, et al.
Publicado: (2018) -
Genome‐wide based model predicting recovery from portosystemic shunting after liver shunt attenuation in dogs
por: Van den Bossche, Lindsay, et al.
Publicado: (2018) -
Ultrasonographic measurement of gallbladder wall thickness in fasted dogs without signs of hepatobiliary disease
por: Martinez, Carlos, et al.
Publicado: (2023) -
Efficacy of orally administered sodium benzoate and sodium phenylbutyrate in dogs with congenital portosystemic shunts
por: van Straten, Giora, et al.
Publicado: (2019)